https://www.nxtpsychedelics.com/news/articles/psychedelics/mindbio-therapeutics-receives-final-regulatory-approval-to-conduct-phase-2b-randomized-controlled-trial-microdosing-mb22001-in-patients-diagnosed-with-major-depressive-disorder/